Accelerated Approval for IgA Nephropathy Treatment
9:09
Behind the Mystery: IgA Nephropathy
30:26
Expert Perspectives on the Future of IgA Nephropathy Treatment
5:35
Explaining Sparsentan’s Full FDA Approval and Other IgA Nephropathy Therapeutic Developments
18:01
Breaking Down the Burden of IgA Nephropathy With Clinician and Patient Perspectives
35:16
IgA Nephropathy Uncovered: Symptoms, Diagnosis & Latest Treatments
25:08
Mike Zimmer: Engineering a less immunogenic bacterial protease for treatment of IgA Nephropathy
7:20
IgA Nephropathy Treatment Options
51:23